BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 10395142)

  • 1. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?
    Abramson MA; Sexton DJ
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):408-11. PubMed ID: 10395142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia.
    Reed SD; Friedman JY; Engemann JJ; Griffiths RI; Anstrom KJ; Kaye KS; Stryjewski ME; Szczech LA; Reller LB; Corey GR; Schulman KA; Fowler VG
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):175-83. PubMed ID: 15756889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.
    Filice GA; Nyman JA; Lexau C; Lees CH; Bockstedt LA; Como-Sabetti K; Lesher LJ; Lynfield R
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):365-73. PubMed ID: 20184420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges.
    Cosgrove SE; Qi Y; Kaye KS; Harbarth S; Karchmer AW; Carmeli Y
    Infect Control Hosp Epidemiol; 2005 Feb; 26(2):166-74. PubMed ID: 15756888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of bloodstream infections caused by methicillin-resistant Staphylococcus aureus at a tertiary care hospital in New York.
    Yasmin M; El Hage H; Obeid R; El Haddad H; Zaarour M; Khalil A
    Am J Infect Control; 2016 Jan; 44(1):41-6. PubMed ID: 26412481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients.
    Greiner W; Rasch A; Köhler D; Salzberger B; Fätkenheuer G; Leidig M
    Clin Microbiol Infect; 2007 Mar; 13(3):264-8. PubMed ID: 17391380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study.
    Rubio-Terrés C; Garau J; Grau S; Martinez-Martinez L;
    Clin Microbiol Infect; 2010 Jun; 16(6):722-8. PubMed ID: 19712112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections.
    McHugh CG; Riley LW
    Infect Control Hosp Epidemiol; 2004 May; 25(5):425-30. PubMed ID: 15188850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital costs in patients with nosocomial methicillin-resistant or methicillin-susceptible Staphylococcus aureus bloodstream infection.
    Vandijck DM; Annemans L; Vogelaers DP; Blot SI
    Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1127; author reply 1128. PubMed ID: 19811101
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan.
    Tsuzuki S; Yu J; Matsunaga N; Ohmagari N
    Public Health; 2021 Sep; 198():292-296. PubMed ID: 34507134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality risk factors with nosocomial Staphylococcus aureus infections in intensive care units: results from the German Nosocomial Infection Surveillance System (KISS).
    Gastmeier P; Sohr D; Geffers C; Behnke M; Daschner F; Rüden H
    Infection; 2005 Apr; 33(2):50-5. PubMed ID: 15827870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission.
    Manzur A; Vidal M; Pujol M; Cisnal M; Hornero A; Masuet C; Peña C; Gudiol F; Ariza J
    J Hosp Infect; 2007 Jun; 66(2):135-41. PubMed ID: 17513007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals.
    Kim T; Oh PI; Simor AE
    Infect Control Hosp Epidemiol; 2001 Feb; 22(2):99-104. PubMed ID: 11232886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of nosocomial staphylococcus aureus bloodstream infection in South Korea: a prospective hospital-based nationwide study.
    Kim CJ; Kim HB; Oh MD; Kim Y; Kim A; Oh SH; Song KH; Kim E; Cho Y; Choi Y; Park J; Kim BN; Kim NJ; Kim KH; Lee E; Jun JB; Kim Y; Kiem S; Choi H; Choo E; Sohn KM; Lee S; Chang H; Bang J; Lee S; Lee J; Park S; Jeon M; Yun N;
    BMC Infect Dis; 2014 Nov; 14():590. PubMed ID: 25891200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
    Melzer M; Eykyn SJ; Gransden WR; Chinn S
    Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare-associated Staphylococcus aureus bloodstream infection: length of stay, attributable mortality, and additional direct costs.
    Primo MG; Guilarde AO; Martelli CM; Batista LJ; Turchi MD
    Braz J Infect Dis; 2012; 16(6):503-9. PubMed ID: 23158266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.